Role of multiparametric magnetic resonance imaging for patients under active surveillance for prostate cancer: a systematic review with diagnostic meta-analysis-Reference-Cited by-同舟云学术

Role of multiparametric magnetic resonance imaging for patients under active surveillance for prostate cancer: a systematic review with diagnostic meta-analysis

Published:2018-11-28 Issue:2 Volume:22 Page:206-220
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Cantiello Francesco,Russo Giorgio Ivan,Kaufmann Sascha,Cacciamani Giovanni,Crocerossa Fabio,Ferro Matteo,De Cobelli Ottavio,Artibani Walter,Cimino Sebastiano,Morgia Giuseppe^ORCID,Damiano Rocco,Nikolaou Konstantin,Kröger Nils,Stenzl Arnulf,Bedke Jens,Kruck Stephan

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

http://www.nature.com/articles/s41391-018-0113-2.pdf

Reference64 articles.

1. Cornford P, Bellmunt J, Bolla M, Briers E, De Santis M, Gross T, et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer. Eur Urol. 2017;71:630–42.

2. Rosenkrantz AB, Verma S, Choyke P, Eberhardt SC, Eggener SE, Gaitonde K, et al. Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR. J Urol. 2016;196:1613–8.

3. Kaufmann S, Russo GI, Bamberg F, Lowe L, Morgia G, Nikolaou K et al. Prostate cancer detection in patients with prior negative biopsy undergoing cognitive-, robotic- or in-bore MRI target biopsy. World J Urol. 2018;36:761–768. https://doi.org/10.1007/s00345-018-2189-7

4. Cantiello F, Russo GI, Cicione A, Ferro M, Cimino S, Favilla V, et al. PHI and PCA3 improve the prognostic performance of PRIAS and Epstein criteria in predicting insignificant prostate cancer in men eligible for active surveillance. World J Urol. 2016;34:485–93.

5. Russo GI, Regis F, Castelli T, Favilla V, Privitera S, Giardina R, et al. A systematic review and meta-analysis of the diagnostic accuracy of Prostate Health Index and 4-Kallikrein panel score in predicting overall and high-grade prostate cancer. Clin Genitourin Cancer. 2017;15:429–39. e421.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adequacy of clinical guideline recommendations for patients with low-risk cancer managed with monitoring: systematic review;Journal of Clinical Epidemiology;2024-05

2. ACR Appropriateness Criteria® Pretreatment Detection, Surveillance, and Staging of Prostate Cancer: 2022 Update;Journal of the American College of Radiology;2023-05

3. A Framework of Analysis to Facilitate the Harmonization of Multicenter Radiomic Features in Prostate Cancer;Journal of Clinical Medicine;2022-12-24

4. A Novel Risk Score (P-score) Based on a Three-Gene Signature, for Estimating the Risk of Prostate Cancer-Specific Mortality;Research and Reports in Urology;2022-05

5. Predictors of upgrading from low-grade cancer at prostatectomy in men with biparametric magnetic resonance imaging;Central European Journal of Urology;2022